Session Details

F055 Dermatopathology Case Challenge: Recognizing Mimics and Masqueraders

Sun, Mar 29, 1:00 PM - 3:00 PM
Bluebird 3E
2 CME Available Forum Upcoming
View Map

DESCRIPTION

Mimics in dermatology and dermatopathology pose a potential pitfall in the accurate diagnosis. This may result in unintentional diagnostic errors and delay of appropriate patient treatment. This session intends to provide dermatopathologists, dermatologists, and those in training with enhanced awareness of both common and novel mimics that may be encountered in dermatopathology practice. An interactive case-based format will be utilized, and speakers will describe masqueraders that they have faced, ancillary tools employed, and the lessons learned in reaching the correct interpretation.

LEARNING OBJECTIVES

1.

Identify diagnostic entities that present as mimics in dermatopathology.

2.

Recognize clinical and histopathologic features that can help avoid diagnostic pitfalls when faced with a dermatopathologic mimic.

3.

Utilize ancillary tests when appropriate to enhance diagnostic accuracy in challenging dermatopathologic cases.

SCHEDULE

1:00 PM

Introduction

Rosalie Elenitsas, MD, FAAD

1:10 PM

Case Presentations

2:50 PM

Questions and Answers

DIRECTOR

Rosalie Elenitsas, MD, FAAD

Rosalie Elenitsas, MD, FAAD

SPEAKERS

Carly Elston, MD, FAAD

Carly Elston, MD, FAAD

Dirk Michael Elston, MD, FAAD

Dirk Michael Elston, MD, FAAD

Tammie C. Ferringer, MD, FAAD

Tammie C. Ferringer, MD, FAAD

Alexandra Flamm, MD, FAAD

Alexandra Flamm, MD, FAAD

Kevin John Gaddis, MD, FAAD

Kevin John Gaddis, MD, FAAD

Ronald P. Rapini, MD, FAAD

Ronald P. Rapini, MD, FAAD

Michi Shinohara, MD, FAAD

Michi Shinohara, MD, FAAD

DISCLOSURES

Rosalie Elenitsas, MD, FAAD

No financial relationships exist with ineligible companies.

Carly Elston, MD, FAAD

No financial relationships exist with ineligible companies.

Dirk Michael Elston, MD, FAAD

No financial relationships exist with ineligible companies.

Tammie C. Ferringer, MD, FAAD

No financial relationships exist with ineligible companies.

Alexandra Flamm, MD, FAAD

No financial relationships exist with ineligible companies.

Kevin John Gaddis, MD, FAAD

No financial relationships exist with ineligible companies.

Ronald P. Rapini, MD, FAAD

No financial relationships exist with ineligible companies.

Michi Shinohara, MD, FAAD

Kyowa Hakko Kirin Pharma, Inc. – Consultant (1099 relationship)(Fees); Kyowa Kirin – Investigator(Grants/Research Funding);